November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Karen Knudsen: I am encouraged by the announcement that coverage for patient navigation is expanding in commercial health insurance plans and comprehensive cancer centers
Mar 13, 2024, 00:00

Karen Knudsen: I am encouraged by the announcement that coverage for patient navigation is expanding in commercial health insurance plans and comprehensive cancer centers

Karen Knudsen shared a post on LinkedIn:

“Navigating a confusing and complex health care system after receiving a cancer diagnosis is difficult for anyone. As such, I am encouraged by the announcement that coverage for patient navigation is expanding in commercial health insurance plans and comprehensive cancer centers, and community oncology clinics are committed to using patient navigation codes to increase coverage.

Increasing coverage of patient navigation will not only improve the patient experience, but improve patient outcomes, bringing us closer to ending cancer as we know it, for everyone.”

Karen Knudsen: I am encouraged by the announcement that coverage for patient navigation is expanding in commercial health insurance plans and comprehensive cancer centers

Read further.
Source: Karen Knudsen/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.